The Legal Action Center is among the advocacy groups concerned that 42 CFR Part 2 changes contained in the House’s opioid bill could harm patient confidentiality.
Industry groups are disappointed over a lack of additional funding and the exclusion of 42 CFR Part 2 reform, and have also called for the removal the IMD exclusion for Medicaid patients.
Although changes to 42 CFR Part 2 took place in recent months, the rule has always been top of mind for treatment centers. And now that legislation passed in June to align privacy for substance-use-…
SAMHSA recently published its long-awaited final rules governing confidentiality of patient records for substance abuse disorders. Here is what treatment centers need to know about them.
Although the proposed rules have yet to be finalized, many addiction treatment providers are asking how to make sure they are in compliance with 42 CFR, Part 2 and how they might prepare for any…
HIEs can help providers offer a higher quality of care that reflects well in a value-based payment model, but significant groundwork must be completed before participating.
A study published by the Association for Behavioral Health and Wellness finds managed care is receptive to medication-assisted treatment, but not all care providers share their point of view.
Though challenges arise, it is essential that behavioral health providers create population health strategies to increase patient engagement and eventually cut healthcare costs.
Under the final rule, providers and others are in fact permitted to disclose private health information under HIPAA—without patient authorization—to the National Instant Criminal…